Herpes simplex virus infections Therapeutic Pipeline Analysis
Added: (Fri Dec 07 2018)
Pressbox (Press Release) -
The study analysed that the Herpes simplex virus infections pipeline comprises of 20 drug candidates in different stages of development.
Browse report sample at: https://www.psmarketresearch.com/market-analysis/hsv-infections-therapeutics-pipeline-analysis/report-sample
Many technologies are being developed that offer promising innovative treatments which can control the progression of Herpes simplex virus infections. The technologies include, but not limited to, Vector based technology platform, AdenoVerse technology platform, Juvari’s technology platform and Nanostat technology platform.
The research found that various companies have collaborated for the development of Herpes simplex virus infections pipeline. In June 2014, PaxVax Inc., entered into a research and development collaboration with the University of California to develop a combination vaccine to prevent genital herpes simplex virus infections.
Browse report at: https://www.psmarketresearch.com/market-analysis/hsv-infections-therapeutics-pipeline-analysis
Some of the key players developing drugs for the treatment of Herpes virus simplex infections include Maruho Co., Ltd., NanoBio Corporation, Lumavita AG and others.